Brief: Avalo Therapeutics Regains Compliance With Nasdaq Listing Rule

Avalo Therapeutics

04/09/2024 12:29

Sept 4 (Reuters) - Avalo Therapeutics Inc  AVTX.O :
    * AVALO THERAPEUTICS - GOT NOTIFICATION FROM NASDAQ THAT CO
REGAINED COMPLIANCE WITH NASDAQ LISTING RULE

Source text for Eikon:  ID:n0001628280-24-039221 
Further company coverage:  AVTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))